Package Label.Principal Display Panel
NDC 70771-1919-1
Methenamine Hippurate Tablets, USP 1gram
100 tablets
Rx only
Image (C3524692 Fabc 438a 9d6e 2cca27172693 01)
Methenamine Hippurate Tablet
FDA Label NDC 70771-1919
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Methenamine Hippurate (NDC 70771-1919). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
* Please review the disclaimer below.
